News
Abbott Launches Next-Gen FreeStyle Libre® 2 Plus with Continuous Glucose Readings Every Minute & Optional Alarms ...
GlobalData on MSN9mon
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster
Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod ...
Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback